Boothbay Fund Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,526
Closed -$715K 2698
2026
Q1
$715K Sell
6,526
-37,472
-85% -$5.34M 0.01% 1143
2025
Q4
$7.32M Buy
43,998
+13,561
+45% +$2.27M 0.11% 197
2025
Q3
$5.96M Sell
30,437
-7,124
-19% -$1.17M 0.09% 267
2025
Q2
$3.4M Buy
37,561
+9,780
+35% +$773K 0.07% 382
2025
Q1
$1.66M Buy
27,781
+11,958
+76% +$1.11M 0.04% 477
2024
Q4
$2.1M Sell
15,823
-22,784
-59% -$2.14M 0.05% 436
2024
Q3
$2.02M Buy
+38,607
New +$1.81M 0.05% 514
2024
Q2
Sell
-3,258
Closed -$242K 1908
2024
Q1
$242K Buy
+3,258
New +$241K ﹤0.01% 1279

Other funds holding ALAB

Boothbay Fund Management's ALAB Position: Q2 2026 in Review

Boothbay Fund Management sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 6,526 shares — an estimated $715K sold.

Boothbay Fund Management first reported a position in ALAB in Q1 2024 and held it in 8 quarters. The position peaked at $7.32M in Q4 2025. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Boothbay Fund Management reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 6,526 Astera Labs shares in Q2 2026, an estimated $715K.
  • Boothbay Fund Management first reported a position in Astera Labs in Q1 2024 and held it in 8 quarters.
  • Boothbay Fund Management's Astera Labs position peaked at $7.32M in Q4 2025.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.